The pharmaceutical industry is poised to stay afloat because of consistent medical breakthroughs and escalating global demand for healthcare. Therefore, quality pharma stocks Johnson & Johnson (JNJ), Novartis AG (NVS), and Dr. Reddy's Laboratories Limited (RDY), with promising pipelines, could be solid buys now.
The pharma industry is anticipated to remain robust in the upcoming months due to the rapid spread of COVID-19's new variants, EG.5 (Eris), accounting for approximately 20% of infections in the United States and BA.2.86. Despite WHO’s assurances of its low risk to public health, the uptick in infections and hospitalizations prompted pharmaceutical leaders to update the existing vaccines.
